One of the known effects of the MOTS-c peptide is related to metabolism. MOTS-c is considered one of the key molecules responsible for regulating metabolism and supporting its improvement.
10,500 UAH
No product image has been added yet
Orders are processed and handed over for delivery within 1–2 business days after confirmation by a manager. We deliver throughout Ukraine with Nova Poshta to a branch, parcel locker, or by courier to your address. Delivery cost is calculated at the carrier’s rates upon receipt.
Payment: Pay on delivery · Card transfer · Bank transfer · Crypto wallet · PayPal
MOTS-C (mitochondrial open reading frame of the 12S rRNA type-c) is a mitochondrially encoded peptide composed of 16 amino acids. It belongs to the group of mitochondrial-derived peptides (MDPs), signaling molecules involved in communication between mitochondria, the cell nucleus, and other tissues.
Scientific interest in MOTS-C is associated with energy metabolism, insulin sensitivity, adaptation to physical exertion, and cellular stress. However, most data on exogenous MOTS-C have been obtained from cellular and animal models. The clinical efficacy and safety of commercial MOTS-C products in humans have not been established.
You can buy MOTS-C in Ukraine for research purposes, compare available concentrations and formats, and check specifications, the current price, and delivery terms.
For research only: MOTS-C is not a registered medicinal product and is not intended for human or veterinary use. The information on this page is not medical advice or a protocol for use.
MOTS-C has been described as a peptide encoded by a short open reading frame in mitochondrial 12S ribosomal RNA. Unlike most peptides, its genetic information is located in the mitochondrial genome rather than the nuclear genome.
Mitochondria do more than produce energy. They also transmit signals about nutrient availability, oxidative stress, and cellular status. MOTS-C is considered one component of this signaling system.
In preclinical studies, the action of MOTS-C is associated with the folate cycle, AICAR accumulation, and activation of AMPK, an enzyme involved in controlling cellular energy balance. This pathway affects glucose utilization, lipid metabolism, and adaptation to energy deficiency.
Under metabolic stress, MOTS-C may move into the nucleus and interact with gene regulation mechanisms. Researchers consider this a possible link between mitochondrial status and the cell's nuclear response.
A description of the molecular mechanism does not mean that the finished product has a proven benefit in humans. The outcome is affected by the substance's purity, stability, composition, route of administration, and compliance with the research protocol.
Scientific publications examine MOTS-C in several areas:
regulation of cellular energy metabolism;
AMPK and PGC-1alpha signaling pathways;
glucose metabolism and insulin sensitivity;
adaptation of skeletal muscles to physical exertion;
mitochondrial response to cellular stress;
age-related changes in metabolism and physical function.
These areas cannot be presented as guaranteed effects. Claims about weight loss, treatment of diabetes, increased endurance, improved sleep, cognitive function, or longevity require high-quality clinical studies of the specific product.
Interest in MOTS-C in the context of body weight arose after animal studies in which changes in insulin sensitivity and metabolic homeostasis were observed. However, MOTS-C should not be placed in the same category as registered weight management products that have clinical programs and approved indications.
In the PeptideCo catalog, MOTS-C may be linked internally to the weight management products section, but the description must clearly indicate its research status and the limited human data.
Research-grade MOTS-C may be supplied in vials and ready-to-use devices. The format affects packaging, concentration, volume, and storage requirements, but does not by itself confirm quality or biological effect.
Compact devices can be compared in the peptide pens section, while the full range is available in the peptides and peptide substances category.
Check the amount of substance. Compare the total amount of MOTS-C with the product volume.
Confirm the concentration. The same number of milligrams in different volumes means different concentrations.
Review the manufacturer. The packaging should state the manufacturer, batch, and expiry date.
Check the certificate of analysis. The COA should correspond to the specific batch number of the product.
Assess purity and identification. The documents should preferably include the analytical methods and the results obtained.
Confirm storage requirements. Follow the manufacturer's requirements for the specific format.
Check integrity. Do not use a sample with damaged packaging or labeling.
The FDA states that no data on human exposure by any route of administration have been identified for formulations containing MOTS-C. The agency also notes potential risks related to immunogenicity, peptide-related impurities, and the difficulty of confirming the characteristics of the active substance.
Therefore, universal dosages, courses, or safety guarantees cannot be established for MOTS-C outside an approved study. Research Use Only labeling must be consistent with the product's intended purpose.
Mots-c 10 mg pen:
1 click = 33.3 mcg
30 clicks = 1 mg
60 clicks = 2 mg
Mots-c 20 mg pen:
1 click = 66.7 mcg
38 clicks = 2.5 mg
45 clicks = 3 mg
75 clicks = 5 mg
Mots-c 40 mg pen:
1 click = 0.133 mg
19 clicks = 2.5 mg
23 clicks = 3 mg
38 clicks = 5 mg
Attention. The information on this website is for informational purposes; the product is not a medicinal product. The appearance of the packaging may be changed by the manufacturer without notice.
The product is intended for research purposes only, not for human use. The information was compiled from numerous studies and analyses conducted over many years and is not intended for the diagnosis, treatment, or prevention of any disease.
*All results are individual and depend on your health status
| Active ingredient | MOTS-c |
|---|---|
| Product form | Pre-filled pen |
| Dosage | 20 mg, 40 mg, 10 mg |
| Volume | 3 ml |
| Route of administration | Subcutaneous injection |
| Requires reconstitution | No |